期刊文献+

促性腺激素释放激素激动剂降调节对血清抗苗勒管激素的影响 被引量:6

Influence of Gonadotropin-releasing Hormone Agonist on Serum Anti-Mullerian Hormone Level
在线阅读 下载PDF
导出
摘要 【目的】探讨两种剂型(长效/短效)促性腺激素释放激素激动剂(GnRH-a)降调节对血清抗苗勒管激素(AMH)的影响是否相同。【方法】选择2012年2月到9月在我中心行体外受精/胞浆内单精子注射-胚胎移植(IVF/ICSI-ET)共869个治疗周期,符合入选标准患者随机进入长效组(使用长效GnRH-a)128例患者128周期;短效组(使用短效GnRH-a)116例患者116周期。降调前月经来潮第3天和降调第14天抽取空腹静脉血检测血清AMH,观察患者用药前后血清AMH变化。【结果】①长效组血清AMH降调后略下降,但P>0.05;短效组降调后下降约0.63μg/L,P<0.05。②两组基础血清AMH降调后均呈现归中趋势。以上升或下降为标准的ROC曲线,寻找切割点。长效组基础血清AMH切割点是2.15μg/L,短效组切割点是2.16μg/L。③长效组切割点以下组52例,降调后AMH(μg/L)由1.39±0.54上升为2.73±1.83,P<0.01;切割点以上组76例,降调后血清AMH(μg/L)为4.40±1.95下降为3.27±1.78,P<0.01。短效组切割点以下组51例,降调后血清AMH(μg/L)由1.21±0.50上升为1.96±1.57,P<0.01;切割点以上组65例,降调后血清AMH(μg/L)由4.26±1.93下降为2.55±1.48,P<0.01。④长效切割点以下组内,血清AMH上升者与下降者基础AMH均值无统计学差异,P>0.05,但上升者获卵数多于下降者(13.4±5.1 vs 7.4±2.5,P<0.05);长效切割点以上组内,血清AMH上升者基础血清AMH均值小于下降者,但获卵数上升组反而多于下降组(17.73±6.13 vs 13.79±4.60)个(P<0.05)。短效组按切割点分组后,结果类似。【结论】无论是使用长效还是短效GnRH-a,降调节前后血清AMH变化规律是一样的:基础AMH低于切割点的呈现上升趋势,高于切割点的呈现下降趋势。符合这一变化规律的患者获卵数的预期结果更好。 [ Objective ] To investigate whether the influence of two forms (long-acting / short-acting) of gonadotrophin-releasing hormone agonist (GnRH-a) on anti-Mullerian hormone (AMH) is the same. [Methods] The study included 869 cycles that underwent in vitro fertilization (IVF) /intracytoplasmic sperm injection (ICSI) from February 2012 to September 2012. Patients who met the inclusion criteria were randomly divided into two groups: long-acting group (using long-acling GnRH-a, Diphereline ) which including 128 women with 128 cycles, and short-acting group (useing short-acting GnRH-a, Diphereline ) which including 116 women with 116 cycles. Serum AMH levels were measured at baseline and Day 14 following GnRH-a. [Results] (1) After down- regulation in long-acting group, baseline serum AMH slightly reduced, P 〉 0.05; In short-acting group, serum AMH fell from (2.92 ± 2.12) μg/L to (2.29 ± 1.54)μg/L (P 〈 0.05). (2) After GnRH-a treatment higher basal AMH level fell down, and lower basal AMH level grew up in both groups. Using rising or failing AMH level as the standard to the ROC curve, we found the cutoff point of serum AMH:2.15 μg/L in long-acting group, and 2.16 μg/L in short-acting group. (3)In long-acting group, based on the cutoff points, basal AMH level of 52 women was less than 2.15 μg/L, and their basal serum AMH was (1.39 ±0.54) μg/L, after down- regulation AMH was (2.73± 1.83) μg/L(P 〈0.01 ) ; 76 women with basal serum AMH 1〉2.15 μg/L, their basal serum AMH was (4.40 ± 1.95)μg/L, after down-regulation was (3.27 ± 1.78) μg/L(P 〈 0.01 ). In short-acting group, 51 women with basal serum AMH 〈 2.16 μg/L, AMH before down-regulation was (1.21 ± 0.50) μg/L, after down-regulation was (1.96 ±1.57) μg/L (P 〈 0.01 ) ; 65 women with basal serum AMH 〉12.16 μg/L, their basal serum AMH was (4.26 ± 1.93) μg/L, after down-regulation was (2.55± 1.48) μg/L (P 〈 0.01 ). (4)In long-acting group, for those whose AMH level 〈 2.15 I.L g/L, there was no significant difference of basal serum AMH between AMH increased group (1.39 ±0.55) μg/L and decreased group (1.41 ± 0.38) μg/L, but the number of retrieved oocytes was less in falling group (13.40 ±5.08 vs 7.40 ±2.51, P 〈 0.05). For those whose AMH level 〉t 2.15μg/L, AMH increased group had lower basal AMH level (3.39±0.89) μg/L than decreased group (4.65 ± 2.06) μg/L, but had more retrieved oocytes ( 17.73 ± 6.13 vs 13.79 ± 4.60, P 〈 0.05). In short-acting group, we had the same results. [Conclusion] Whether using long-acting or short-acting GnRH-a, AMH dynamics after down regulation was the same: for those with basal serum AMH below the cutoff point, AMH had upward trend; for those with basal serum AMH higher than the cutoff point, AMH showed downward trend. Consistent with this variation trend, the expected number of oocytes retrieved would be better.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2013年第4期578-584,共7页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省医学科研基金(A2011747)
关键词 抗苗勒管激素 垂体降调节 控制性超排卵 anti-Mullerian hormone (AMH) pituitary down-regulation controlled ovarian stimulation
  • 相关文献

参考文献14

  • 1Ye Y,Wu R,Ou J.Prediction of ovarian response on AMH concentrations before and after pituitary down-regulation in COH[J].Hum Reprod (Abstract book),2010,25(1):i310-i310.
  • 2Jayaprakasan K,Campbell BK,Hopkisson JF,et al.Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone[J].Hum Reprod,2008,23 (11):2577-2583.
  • 3Popovic-Todorovic B,Loft A,Lindhard A,et al.A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH.A suggestion for a recombinant FSH dosage normogram[J].Hum Reprod,2003,18 (4):781-787.
  • 4叶云,吴日然,欧建平,林秀峰,廖月婵,杜静,杜彦.降调前后抗苗勒管激素预测控制性卵巢刺激中卵巢反应性的临床研究[J].生殖医学杂志,2010,19(4):295-300. 被引量:7
  • 5Ficicioglu C,Kutlu T,Baqlam E,et al.Early follicular anti-Müllerian hormone as an indicator of ovarian reserve[J].Fertil Steril,2006,85(3):592-596.
  • 6La Marca A,Sighinolfi G,Radi D,et al.AntiMullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)[J].Hum Reprod Update.2010,16(2):113-130.
  • 7Seifer DB,MacLaughlin DT,Penzias AS,et al.Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen content[J].Clin Endocrinol Metab,1993,76(3):711-714.
  • 8van Rooij IA,Broekmans1 FT,Velde1 ER,et al.Serum anti-Mu¨ llerian hormone levels:a novel measure of ovarian reserve[J].Hum Reprod,2002,17 (12):3065-3071.
  • 9Pe(n)arrubia J,Fábregues F,Manau D,et al.Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonistgonadotropin treatment[J].Hum Reprod,2005,20(4):915-922.
  • 10Mohamed KA,Davies WA,Lashen H.Anti-müllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate[J].Fertil Steril,2006,86(5):1515-1517.

二级参考文献46

  • 1赵晓明,毛宇红,刘芳荪,孙赟,洪燕,林其德.卵巢储备功能测定在体外受精(IVF)技术中的临床价值探讨[J].生殖与避孕,2005,25(8):465-468. 被引量:13
  • 2Luk Rombauts.Is there a recommended maximum starting dose of FSH in IVF?[J].Assist Reprod Genet,2007,24(8):343-349.
  • 3Durlinger AL,Visser JA,Themmen AP.Regulation of ovarian function:the role of anti-Müllerian hormone[J].Reproduction,2002,124 (5):601-609.
  • 4Rooij IA,Frank JM,Scheffe GJ.Serum anti-Müllerian hormone levels best refect the reproductive decline with age in normal women with proven fertility:a longitudinal study[J].Fertil Steril,2005,83 (4):979-987.
  • 5Eldar-Geva T,Ben-Chetrit A,Spitz IM,et al.Dynamic assays of inhibin B,anti-Müllerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome[J].Hum Reprod,2005,20(11):3178-3183.
  • 6Ficicioglu C,Kutlu T,Baqlam E,et al.Early follicular anti-Müllerian hormone as an indicator of ovarian reserve[J].Fertil Steril,2006,85(3):592-596.
  • 7La Marca A,Giulini S,Tirelli A,et al.Anti-Mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology[J].Hum Reprod,2007,22(3):766-771.
  • 8Lee TH,Liu CH,Huang CC,et al.Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles[J].Hum Reprod,2008,23(1):160-167.
  • 9Jayaprakasan K,Campbell B K,Hopkisson J F,et al.Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Müllerian hormone[J].Hum Reprod,2008,23(11):2577-2583.
  • 10Leung PC,Chen CK,Zhu XM.Multi-factorial role of GnRH-I and GnRH-II in the human ovary[J].Mol Cell Endocrinol,2003,202(1-2):145-153.

共引文献34

同被引文献53

  • 1JAYAPRAKASAN K, CAMPBELL B, HOPKISSON J, et al. A prospective, comparative analysis of anti-Mtillerian hor- mone, inhibin-B, and three-dimensional ultrasound determi- nants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation [Jl. Fertility and Sterility, 2010,93(3) : 855-864.
  • 2BROER S L, VAN DISSELDORP J, BROEZE K A, et al. Added vaiue of ovarian reserve testing on patient characteris- tics in the prediction o[ ovarian response and ongoing pregnan cy: an individual patient data approach[J]. Human Reproduc- tion Update, 2012,19(1) :26-36.
  • 3JAYAPRAKASAN K, CAMPBELL B K, HOPKISSON J F, et al. Effect of pituitary desensitization on the early growing follieular cohort estimated using anfi-Muller an hormone[J], Human Reproduction (Oxford, England), 2008, 23 (11) 2577-2583 476.
  • 4SEIFER D B, MACLAUGHLIN D T, PENZIAS A S, et al. Gonadotropin-releasing hormone agonist-induced differences in granulosa eell cycle kinetics are associated with alterations in follicular fluid mtillerianqnhibiting substance and androgen content[J]. The Journal o{ Clinical Endoerinol.ogy and Meta- bolism, 1993,76(3) :711-714.
  • 5MOHAMED K A, DAVIES W A, LASHEN H. Antimt:lle rian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate[J]. Fertility and Steri- lity, 2006,86(5) :1515-1517.
  • 6NARDO L G, GELBAYA T A, WILKINSON H, et al. Cir- culating basal anti Miillerian hormone levels as predictor of o- varian response in women undergoing ovarian stimulation for in vitro fertilization[J]. Fertility and Sterility, 2009,92 (5) 1586-1593.
  • 7LEE T H, LIU C H, HUANG C C, et al. Serum anti- Miillerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles[J]. Human Reproduction (Oxford, England), 2008,23 (1) :160-167.
  • 8叶云,欧建平,吴日然,林秀峰,廖月婵,杜静,杜彦.血清抗苗勒管激素水平预测卵巢储备及在控制性超排卵中的应用[J].中山大学学报(医学科学版),2010,31(5):666-671. 被引量:19
  • 9王锦惠,门殿霞,于子芳,闫芳,李春敏,肖文丽,张烁.经阴道彩色多普勒超声评价体外受精-胚胎移植子宫内膜容受性的价值[J].中国超声医学杂志,2011,27(4):349-352. 被引量:16
  • 10朱光丽,苏迎春,孙莹璞,郭艺红,胡琳莉.人绒毛膜促性腺激素注射日血清孕酮水平对体外受精妊娠结局的影响[J].现代妇产科进展,2011,20(4):286-289. 被引量:5

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部